Abstract
Systemic sclerosis (SSc) is a rare connective tissue disorder whose aetiology remains obscure, although environmental and genetic influences are likely to play a role. Disease registries have contributed to enhancing our understanding of this debilitating illness, but without sensitive, specific, and extensively validated classification criteria, accurate comparison between registries and the identification of patients suitable for clinical trials can be problematic. The American College of Rheumatology (ACR) criteria, published in 1980, have become outdated as our understanding of disease specific autoantibodies and nailfold capillaroscopy has improved. In addition, the sensitivity of the ACR criteria is low with respect to limited SSc. Although subsequent classification systems have been proposed, none has gained universal approval. The two- versus three-subset disease model remains a point of debate. Newly derived criteria are likely to draw upon the older classification systems as well as incorporating up-to-date diagnostic techniques and biomarkers. Validation will be critical before their use becomes widespread.
Similar content being viewed by others
Abbreviations
- ACR:
-
American College of Rheumatology
- anti-CENP:
-
anti-centromere protein
- CTD:
-
connective tissue disease
- dcSSc:
-
diffuse cutaneous systemic sclerosis
- lcSSc:
-
limited cutaneous systemic sclerosis
- PM/DM:
-
polymyositis/dermatomyositis
- SARD:
-
systemic autoimmune rheumatic diseases
- SLE:
-
systemic lupus erythematosus
- SSc:
-
systemic sclerosis
- topo I:
-
topoisomerase I
References
Tan FK (2003) Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 29:211–237
Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y (2005) New therapeutic strategies for systemic sclerosis—a critical analysis of the literature. Clin Dev Immunol 12(3):165–173
Mayes MD, Giannini EH, Pachman LM et al (1997) Connective tissue disease registries. Arthritis Rheum 40:1556–1559
Barnett AJ, Miller MH, Littlejohn GO (1988) A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 15(2):276–283 (Feb)
Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3 Suppl 33):S5–S13 (Jan–Feb)
Steen VD, Oddis CV, Conte CG et al (1997) Incidence of systemic sclerosis in Allegheny county, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum 40(3):441–445
LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576
Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590
LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205 (Feb)
Nadashkevich N, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10(11):CR615–CR621
Fries JF, Hochberg MC, Medsger TA Jr et al (1994) Criteria for rheumatic disease. Different types and different functions. Arthritis Rheum 37(4):454–462
Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis. Arthritis Rheum 52(4):1000–1008
Classification and response criteria subcommittee of the American College of Rheumatology Committee on Quality Measures (2006) Development of classification and response criteria for rheumatic diseases. Arthritis Rheum (Arthritis Care and Research) 55(3):348–352
Felson DT, Anderson JJ (1995) Methodological and statistical approaches to criteria development in rheumatic diseases. Bailliere’s Clin Rheumatol 9:253–266
Maricq HR, Weinrich MC, Keil JE et al (1989) Prevalence of the scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 32(8):998–1006
Steen V, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437–2444
Steen V, Medsger TA Jr (2001) Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44(12):2828–2835
Giordano M, Valentini G, Migliaresi S et al (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911–916
Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine (Baltimore) 81(2):139–153
Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81(2):154–167
Tuffanelli DL, Winkelmann RK (1962) Diffuse systemic scleroderma. A comparison with acrosclerosis. Ann Intern Med 57:198–203
Masi AT (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 15(6):894–898 (Jun)
Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755
Reveille JD, Solomon DH, The American College of Rheumatology Ad hoc Committee on Immunologic Testing Guidelines (2003) Evidence-based guidelines for the use of immunologic tests: anticentromere, Sl–70 and nucleolar antibodies. Arthritis Rheum 49(3):399–412
Arnett F, Reveille JD, Goldstein R et al (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serological and clinical analysis. Arthritis Rheum 39:1151–1160
Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 44:1212–1216
Cepeda EJ, Reveille JD (2004) Antibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 16:723–732
Fritzler MJ (2006) Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15:422–427
Steen VD, Powell DL (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with progressive systemic sclerosis. Arthritis Rheum 31:196–203
Bernstein RM, Steigerwald JC, Tan EM (1982) Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Rheumatol 48(1):43–51
Satiago M, Baron M, Burlingame RW et al (2007) Antibodies to RNA polymerase III in systemic sclerosis as detected by an ELISA. Arthritis Rheum (Arthritis Care and Research) (submitted for publication, January 2007)
Tormey VJ, Bunn CC, Denton CP et al (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology (Oxford) 40(10):1157–1162
Brown GE, O’Leary PA (1925) Skin capillaries in scleroderma. Arch Intern Med 36:73–88
Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628
Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19(3):437–452
Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24(9):1159–1165
Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160
Nagy Z, Czirjak L (2004) Nailfold digital capillaroscopy in 447 patients with connectiv tissue disease ad Raynaud’s diseases. J Eur Dermatol Acad Venereol 18:62–68
Cutolo M, Pizzorni C, Tuccio A et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 43:719–726
Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold video capillaroscopy—a new tool for assessment of Rayaud’s phenomenon. J Rheumatol 32:841–848
Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–1030
Baron M, Bell M, Bookman A et al (2007) Office capillaroscopy in systemic sclerosis. Clin Rheum (in press)
Capusan I (1972) Curzio’s case of scleroderma (letter). Ann Intern Med 76(1):146
Barnett AJ (1978) Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 patients. Med J Aust 2(4):129–134
Rodnan GP, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22(2):130–140
Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281–286
Vayssairat M, Baudot N, Abuaf N et al (1992) Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations. Clin Rheum 11(3):356–363
Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735–736 (Mar)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walker, J.G., Pope, J., Baron, M. et al. The development of systemic sclerosis classification criteria. Clin Rheumatol 26, 1401–1409 (2007). https://doi.org/10.1007/s10067-007-0537-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0537-x